These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 32547595)
1. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer. Chen P; He J; Ye H; Jiang S; Li Y; Li X; Wan J Front Genet; 2020; 11():456. PubMed ID: 32547595 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
3. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma. Liu Y; Jia W; Li J; Zhu H; Yu J Front Oncol; 2020; 10():587343. PubMed ID: 33117720 [No Abstract] [Full Text] [Related]
4. Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer. Wang C; Zheng M; Wang S; Nie X; Guo Q; Gao L; Li X; Qi Y; Liu J; Lin B Biomed Res Int; 2019; 2019():2686875. PubMed ID: 31355251 [TBL] [Abstract][Full Text] [Related]
5. Role of alternative splicing events in endometrial cancer prognosis. Liu J; Mi C; Long W; Sun T Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):680-688. PubMed ID: 34382583 [TBL] [Abstract][Full Text] [Related]
6. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma. Lai J; Yang H; Xu T BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data. Ye P; Yang Y; Zhang L; Zheng G Front Oncol; 2021; 11():658262. PubMed ID: 34676158 [TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
9. Characterization of alternative splicing events and prognostic signatures in breast cancer. Han P; Zhu J; Feng G; Wang Z; Ding Y BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836 [TBL] [Abstract][Full Text] [Related]
10. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis. Lin P; He RQ; Huang ZG; Zhang R; Wu HY; Shi L; Li XJ; Li Q; Chen G; Yang H; He Y Aging (Albany NY); 2019 Apr; 11(7):2082-2097. PubMed ID: 30986203 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma. Duan Y; Zhang D J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370 [TBL] [Abstract][Full Text] [Related]
12. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data. Zhang D; Zhang W; Sun R; Huang Z Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer. Wang Q; Xu T; Tong Y; Wu J; Zhu W; Lu Z; Ying J Mol Ther Nucleic Acids; 2019 Dec; 18():1039-1048. PubMed ID: 31785579 [TBL] [Abstract][Full Text] [Related]
14. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer. Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333 [TBL] [Abstract][Full Text] [Related]
16. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma. Zhang D; Duan Y; Cun J; Yang Q Front Genet; 2019; 10():278. PubMed ID: 30984247 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of survival-associated alternative splicing events in gastric cancer. Zhang S; Hu Z; Lan Y; Long J; Wang Y; Chen X; Xu X; Zeng Z; Ouyang Y Aging (Albany NY); 2020 Nov; 12(21):21923-21941. PubMed ID: 33186122 [TBL] [Abstract][Full Text] [Related]
18. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer. Xu L; Pan J; Ding Y; Pan H Front Genet; 2020; 11():522383. PubMed ID: 33193606 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer. Yang X; Li X; Cheng Y; Zhou J; Shen B; Zhao L; Wang J Front Cell Dev Biol; 2021; 9():797826. PubMed ID: 35223866 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases. He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]